NDS Updates

National Drug Schedules: Final Recommendations for Brimonidine Tartrate Ophthalmic Solution in Concentrations up to and Including 0.025%

The interim recommendations made by the National Drug Scheduling Advisory Committee (NDSAC) on September 18, 2022 that: were finalized effective November 10, 2022. Final approval of the interim recommendations was

National Drug Schedules: Final Recommendations for Brimonidine Tartrate Ophthalmic Solution in Concentrations up to and Including 0.025% Read More »